Search Results 31-40 of 16686 for villous atrophy
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
This study is designed to gain a better understanding of the mechanisms leading to muscle wasting and metabolic abnormalities in skeletal muscle of cancer ...
Incidence of anterior cruciate ligament (ACL) ruptures disproportionately affect female athletes at a rate 4-6 times greater than male counterparts. In addition ...
The purpose of stiudy is to assess whether the fecal microbiomes of patients with progressive MSA exhibit deviations in microbial species composition, proteins, ...
The purpose of this study is to compare the effectiveness of BHV-3241 versus placebo in subjects with Multiple System Atrophy. Participation eligibility.
Mayo Clinic researchers study risk factors, predictors, diagnostic techniques and potential treatments for posterior cortical atrophy, Alzheimer's disease and ...
Multiple system atrophy (MSA) is a rare, rapidly progressive, and invariably fatal neurological condition characterized by autonomic failure, parkinsonism, and/ ...
Hello, my name is Joe Murray. I'm a gastroenterologist in the Celiac Disease Program at Mayo Clinic. One of the challenges of following our patients with ...
Biopsy-confirmed CD (intestinal histology showing villous atrophy). Positive for human leukocyte antigen (HLA)-DQ2 or HLA-DQ2/DQ8 - results will be obtained ...
Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.